IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MANCINI, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.728
NA - Nord America 2.361
AS - Asia 2.351
SA - Sud America 199
AF - Africa 80
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.729
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.232
DE - Germania 747
CN - Cina 637
GB - Regno Unito 635
SG - Singapore 635
IT - Italia 384
VN - Vietnam 329
SE - Svezia 267
HK - Hong Kong 204
BD - Bangladesh 187
BR - Brasile 160
RU - Federazione Russa 154
FR - Francia 115
CA - Canada 104
IN - India 94
TR - Turchia 79
NL - Olanda 70
IE - Irlanda 62
FI - Finlandia 60
DK - Danimarca 44
CI - Costa d'Avorio 39
KR - Corea 37
UA - Ucraina 37
JP - Giappone 36
ID - Indonesia 25
BE - Belgio 21
PL - Polonia 19
AT - Austria 16
AR - Argentina 15
PH - Filippine 15
CH - Svizzera 14
GR - Grecia 14
CZ - Repubblica Ceca 13
ES - Italia 13
MX - Messico 11
IQ - Iraq 10
ZA - Sudafrica 10
IR - Iran 9
AU - Australia 8
EU - Europa 8
PT - Portogallo 8
CL - Cile 7
HU - Ungheria 7
PK - Pakistan 7
RO - Romania 7
KE - Kenya 6
MY - Malesia 6
EC - Ecuador 5
NO - Norvegia 5
NP - Nepal 5
SC - Seychelles 5
UZ - Uzbekistan 5
CR - Costa Rica 4
MA - Marocco 4
PE - Perù 4
SA - Arabia Saudita 4
SV - El Salvador 4
AE - Emirati Arabi Uniti 3
BH - Bahrain 3
BY - Bielorussia 3
CO - Colombia 3
KZ - Kazakistan 3
LT - Lituania 3
MU - Mauritius 3
TH - Thailandia 3
TN - Tunisia 3
AO - Angola 2
AZ - Azerbaigian 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
GY - Guiana 2
JO - Giordania 2
KG - Kirghizistan 2
LU - Lussemburgo 2
OM - Oman 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
IL - Israele 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
ME - Montenegro 1
NZ - Nuova Zelanda 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 7.736
Salva come PNG Salva come JPEG
Città #
Southend 562
Hanover 535
Singapore 357
Ashburn 319
Chandler 208
Hong Kong 174
San Jose 158
Milan 150
Beijing 119
Dallas 97
Ho Chi Minh City 93
Los Angeles 87
Wilmington 84
New York 79
Council Bluffs 74
Hanoi 69
Princeton 67
Ann Arbor 61
Dublin 60
Seattle 54
Santa Clara 53
Istanbul 51
Fairfield 49
Lauterbourg 46
Toronto 42
Buffalo 40
Abidjan 39
Frankfurt am Main 35
Ottawa 35
Helsinki 34
Bengaluru 30
Houston 30
Des Moines 28
Hangzhou 28
Moscow 27
Rome 27
Boardman 26
Guangzhou 26
Da Nang 25
Dearborn 24
Columbus 23
Woodbridge 23
Nanjing 22
Seoul 22
Hefei 21
Redwood City 21
Shanghai 21
Phoenix 20
Tokyo 20
Cambridge 18
Munich 18
Brussels 17
Jakarta 16
São Paulo 15
The Dalles 15
Falls Church 14
Berlin 12
Boston 12
Grafing 12
Haiphong 12
Jinan 12
Fremont 11
Mountain View 11
Zhengzhou 11
Cangzhou 10
Dong Ket 10
Fuzhou 10
Redmond 10
Shenyang 10
Warsaw 10
Denver 9
Tianjin 9
Turku 9
Amsterdam 8
Bến Tre 8
Chennai 8
Clark 8
Prague 8
Wuhan 8
Athens 7
Cagliari 7
Can Tho 7
Hebei 7
Johannesburg 7
London 7
Montreal 7
Mumbai 7
Naples 7
New Delhi 7
North Bergen 7
Orem 7
Sakarya 7
Ankara 6
Brooklyn 6
Central District 6
Jacksonville 6
Manchester 6
Medford 6
Nha Trang 6
Saint Petersburg 6
Totale 4.775
Salva come PNG Salva come JPEG
Nome #
Whole-exome sequencing to identify genetic risk variants underlying inhibitor development in severe hemophilia A patients 502
Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patients 422
ADAMTS13-RELATED ASSAYS IN ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA 323
Thrombotic Thrombocytopenic Purpura (TTP) Database 322
Pro-coagulant imbalance in patients with community acquired pneumonia assessed on admission and one month after hospital discharge 259
ADAMTS13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura 258
The HLA Variant rs6903608 Is Associated with Disease Onset and Relapse of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Caucasians 254
Evaluation of a New, Rapid, Fully Automated Assay for the Measurement of ADAMTS13 Activity 239
Next-generation DNA sequencing to identify novel genetic risk factors for cerebral vein thrombosis 225
Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura 225
The ISTH Bleeding Assessment Tool and the risk of future bleeding 220
ADAMTS13 activity, high VWF and FVIII levels in the pathogenesis of deep vein thrombosis 216
The ADAMTS13-von Willebrand factor axis in COVID-19 patients 214
Different clinical severity of first episodes and recurrence of thrombotic thrombocytopenic purpura 213
Prevalence of the age-related diseases in older patients with acquired thrombotic thrombocytopenic purpura 207
Measurement and prevalence of circulating ADAMTS13-specific immune complexes in autoimmune thrombotic thrombocytopenic purpura 206
Prevention of relapse in patients with acquired thrombotic thrombocytopenic purpura undergoing elective surgery: a case series 203
FRETS-VWF73 rather than CBA assay reflects ADAMTS13 proteolytic activity in acquired thrombotic thrombocytopenic purpura patients 201
ADAMTS13-specific circulating immune complexes as potential predictors of relapse in patients with acquired thrombotic thrombocytopenic purpura 200
Congenital and acquired ADAMTS13 deficiency: two mechanisms, one patient 184
Bortezomib for rituximab-refractory immune-mediated thrombotic thrombocytopenic purpura in the caplacizumab era: an Italian multicenter study 176
Immunochip analysis identifies novel susceptibility loci in the human leukocyte antigen region for acquired thrombotic thrombocytopenic purpura 172
Role of ADAMTS13, VWF and F8 genes in deep vein thrombosis 171
Risk of diagnostic delay in congenital thrombotic thrombocytopenic purpura 168
Measurement of anti-ADAMTS13 neutralising autoantibodies: a comparison between CBA and FRET assays 167
Dramatic presentation of acquired thrombotic thrombocytopenic purpura associated with COVID-19 166
Two novel heterozygote missense mutations of the ADAMTS13 gene in a child with recurrent thrombotic thrombocytopenic purpura 165
Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project) 156
Case report : use of thienopyridines in a patient with acquired idiopathic thrombotic thrombocytopenic purpura 153
Lombardy diagnostic and therapeutic network of thrombotic microangiopathy 147
The features of acquired thrombotic thrombocytopenic purpura occurring at advanced age 135
Thrombotic thrombocytopenic purpura and defective apoptosis due to CASP8/10 mutations: The role of mycophenolate mofetil 124
Factor V Leiden but Not Factor II 20210G>A Is a Risk Factor in a Large Cohort of Iranian Patients with Premature Coronary Artery Disease 124
Lombardy Network for the Study and Treatment of Patients Undergoing Apheresis 124
Evaluation of different platelet-dependent von Willebrand factor activity assays to assess the in vivo inhibitory effect of caplacizumab on the von Willebrand factor–platelet interaction 111
Anti-ADAMTS13 Autoantibodies against Cryptic Epitopes in Immune-Mediated Thrombotic Thrombocytopenic Purpura 109
Lombardy network for the study and treatment of patients undergoing apheresis 101
Acquired Thrombotic Thrombocytopenic Purpura Occurring in Advanced Age : Impact of a Delayed Onset on Disease Expression 88
Efficacy and safety of azathioprine during remission of immune-mediated thrombotic thrombocytopenic purpura 86
Therapeutic plasma exchange-related complications in patients with immune-mediated thrombotic thrombocytopenic purpura: Complications of therapeutic plasma-exchange 80
Factor V Leiden but not factor II 20210G>A is a risk factor in a large cohort of Iranian patients with premature coronary artery disease 74
Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura 72
Efficacy and Safety of Azathioprine during Remission of Immune-Mediated Thrombotic Thrombocytopenic Purpura 70
The features of acquired thrombotic thrombocytopenic purpura occurring at advanced age 4
Totale 8.036
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.360
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.360
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202165 0 0 0 0 0 0 0 0 0 0 0 65
2021/20221.158 48 39 51 100 106 93 107 86 144 141 105 138
2022/2023712 102 115 70 69 76 119 7 54 61 2 24 13
2023/2024370 17 34 41 21 68 31 20 16 14 23 40 45
2024/20251.093 37 63 12 106 85 46 42 118 75 127 114 268
2025/20262.939 273 156 225 301 232 187 531 98 236 172 277 251
Totale 8.036